FRM
TECH icon

Fox Run Management’s Bio-Techne TECH Stock Holding History

Fox Run Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,556
Closed -$208K – 1225
2025
Q1 		$208K Sell
3,556
-16,529
-82% -$1.12M 0.03% 788
2024
Q4 		$1.45M Buy
+20,085
New +$1.47M 0.26% 64
2024
Q3 		– Sell
-16,449
Closed -$1.18M – 1093
2024
Q2 		$1.18M Buy
+16,449
New +$1.21M 0.22% 135
2023
Q4 		– Sell
-5,898
Closed -$401K – 1018
2023
Q3 		$401K Buy
+5,898
New +$466K 0.12% 340
2023
Q2 		– Sell
-16,841
Closed -$1.25M – 951
2023
Q1 		$1.25M Buy
16,841
+12,183
+262% +$939K 0.41% 24
2022
Q4 		$386K Buy
+4,658
New +$370K 0.16% 253

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Fox Run Management's TECH Position: Q2 2025 in Review

Fox Run Management sold out of Bio-Techne (TECH) in Q2 2025, closing a stake of 3,556 shares — an estimated $208K sold.

Fox Run Management first reported a position in TECH in Q4 2022 and held it in 6 quarters. The position peaked at $1.45M in Q4 2024. 554 funds tracked by Wall St. Rank hold TECH as of Q2 2025.

  • Fox Run Management reported no remaining Bio-Techne position as of Q2 2025 after selling out during the quarter.
  • Fox Run Management sold 3,556 Bio-Techne shares in Q2 2025, an estimated $208K.
  • Fox Run Management first reported a position in Bio-Techne in Q4 2022 and held it in 6 quarters.
  • Fox Run Management's Bio-Techne position peaked at $1.45M in Q4 2024.
  • 554 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2025.

Based on Fox Run Management's 13F filing for Q2 2025, filed 6 Aug 2025.